Solara Active Pharma Sciences Ltd.
•₹ 636.215.66%
2026-08-20
PROS
- Promoters have been increasing their shareholding - up 4.7pp over 2 years
- Latest quarter profit grew 55.0% YoY, showing strong momentum
- Operating margins have improved to 16.1% from 7.9%
- Company generates healthy free cash flow
CONS
- A large part of profit comes from other income (1540.7% of PBT)
- Recent results are weak - TTM profit is down 109.6% versus prior year
- Company has a low return on equity of -16.0% over last 3 years
- Company has a low return on capital employed of -3.1%
- Poor cash conversion - profits are not backed by operating cash flow (CFO/PAT -0.81x)
- Interest coverage is weak at 1.0x - earnings barely cover interest
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
EDIT COLUMNS| S.No. | Name | CMP Rs. | P/E | Mar Cap Rs.Cr. | Div Yld % | NP Qtr Rs.Cr. | Qtr Profit Var % | Sales Qtr Rs.Cr. | Qtr Sales Var % | ROCE % | OPM % |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | SUNPHARMA | 1876.40 | 37.22 | 450211.21 | 0.85 | 2901.23 | 26.53 | 15299.88 | 10.98 | 19.11 | 28.81 |
| 2. | DIVISLAB | 8600.00 | 78.05 | 228302.98 | 0.35 | 902.00 | 65.50 | 3080.00 | 27.80 | 21.51 | 40.75 |
| 3. | TORNTPHARM | 4975.00 | 86.76 | 189233.01 | 0.76 | 566.00 | 3.28 | 4921.00 | 57.32 | 19.27 | 33.81 |
| 4. | CIPLA | 1431.85 | 34.32 | 115672.46 | 0.91 | 785.55 | -39.18 | 7119.28 | 4.13 | 16.00 | 16.73 |
| 5. | ZYDUSLIFE | 1117.00 | 24.69 | 111421.18 | 0.09 | 990.20 | -34.90 | 8017.00 | 23.97 | 21.39 | 24.54 |
| 6. | LUPIN | 2225.00 | 18.40 | 101734.76 | 0.81 | 1416.98 | 16.01 | 8276.89 | 34.28 | 28.86 | 29.59 |
| 7. | MANKIND | 2390.00 | 48.32 | 98706.04 | 0.04 | 574.09 | 29.12 | 4030.59 | 12.89 | 13.24 | 26.30 |
| 8. | DRREDDY | 1180.50 | 30.58 | 98533.48 | 0.68 | 435.60 | -69.10 | 8099.80 | -5.21 | 13.75 | 10.63 |
| 9. | LAURUSLABS | 1814.40 | 89.66 | 98034.25 | 0.11 | 362.07 | 123.94 | 2026.31 | 29.10 | 18.20 | 31.50 |
| 10. | AUROPHARMA | 1638.45 | 25.39 | 94272.79 | 0.24 | 1032.03 | 25.22 | 9150.35 | 17.44 | 12.76 | 20.54 |
| 11. | BIOCON | 418.00 | 137.54 | 68121.21 | 0.12 | 136.80 | 53.36 | 4336.00 | 10.89 | 3.26 | 19.54 |
| 12. | SOLARA | 547.55 | 0.00 | 2641.96 | 0.00 | 163.10 | 1450.38 | 3816.00 | 1095.68 | 6.07 | 16.24 |
Detailed Comparison with:
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 352 | 425 | 212 | 299 | 363 | 347 | 300 | 273 | 319 | 314 | 349 | 387 | 382 | |
| 333 | 388 | 374 | 290 | 322 | 286 | 243 | 228 | 262 | 279 | 312 | 330 | 368 | |
| Operating Profit | — | — | — | — | — | — | — | — | — | — | — | — | — |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Income | 2 | 1 | 0 | 2 | 1 | 0 | 1 | 6 | 1 | 0 | 0 | 5 | 3 |
| Interest | 25 | 24 | 25 | 31 | 31 | 28 | 27 | 29 | 24 | 21 | 22 | 28 | 22 |
| Depreciation | 26 | 26 | 26 | 25 | 25 | 25 | 25 | 24 | 24 | 24 | 26 | 26 | 27 |
| -29 | -17 | -275 | -167 | -13 | 8 | 8 | -2 | 11 | -10 | -17 | 10 | 16 | |
| Tax % | 34.91% | -0.00% | -0.00% | -53.28% | -0.00% | 0.00% | 0.00% | -0.00% | 0.00% | -0.00% | -0.00% | 0.00% | 0.00% |
| Net Profit | 0 | 0 | 0 | 0 | -13 | 8 | 8 | -2 | 11 | -10 | -17 | 10 | 16 |
| -5 | -4 | -72 | -67 | -4 | 3 | 2 | -1 | 2 | -2 | -4 | 2 | 0 | |
| Equity Capital | 36 | 36 | 36 | 36 | 40 | 40 | 40 | 40 | 44 | 44 | 44 | 45 | 48 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Equity Capital | 36 | 36 | 36 | 36 | 40 | 40 | 40 | 40 | 44 | 44 | 44 | 45 | 48 |
| Reserves | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Promoter Pledge % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Jun 2023
- 352
- 333
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 25
- Depreciation
- 26
- -29
- Tax %
- 34.91%
- Net Profit
- 0
- -5
- Equity Capital
- 36
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 36
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2023
- 425
- 388
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 24
- Depreciation
- 26
- -17
- Tax %
- -0.00%
- Net Profit
- 0
- -4
- Equity Capital
- 36
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 36
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2023
- 212
- 374
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 25
- Depreciation
- 26
- -275
- Tax %
- -0.00%
- Net Profit
- 0
- -72
- Equity Capital
- 36
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 36
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2024
- 299
- 290
- Operating Profit
- —
- OPM %
- —
- Other Income
- 2
- Interest
- 31
- Depreciation
- 25
- -167
- Tax %
- -53.28%
- Net Profit
- 0
- -67
- Equity Capital
- 36
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 36
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2024
- 363
- 322
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 31
- Depreciation
- 25
- -13
- Tax %
- -0.00%
- Net Profit
- -13
- -4
- Equity Capital
- 40
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 40
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2024
- 347
- 286
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 28
- Depreciation
- 25
- 8
- Tax %
- 0.00%
- Net Profit
- 8
- 3
- Equity Capital
- 40
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 40
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2024
- 300
- 243
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 27
- Depreciation
- 25
- 8
- Tax %
- 0.00%
- Net Profit
- 8
- 2
- Equity Capital
- 40
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 40
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2025
- 273
- 228
- Operating Profit
- —
- OPM %
- —
- Other Income
- 6
- Interest
- 29
- Depreciation
- 24
- -2
- Tax %
- -0.00%
- Net Profit
- -2
- -1
- Equity Capital
- 40
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 40
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2025
- 319
- 262
- Operating Profit
- —
- OPM %
- —
- Other Income
- 1
- Interest
- 24
- Depreciation
- 24
- 11
- Tax %
- 0.00%
- Net Profit
- 11
- 2
- Equity Capital
- 44
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 44
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Sep 2025
- 314
- 279
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 21
- Depreciation
- 24
- -10
- Tax %
- -0.00%
- Net Profit
- -10
- -2
- Equity Capital
- 44
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 44
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Dec 2025
- 349
- 312
- Operating Profit
- —
- OPM %
- —
- Other Income
- 0
- Interest
- 22
- Depreciation
- 26
- -17
- Tax %
- -0.00%
- Net Profit
- -17
- -4
- Equity Capital
- 44
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 44
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Mar 2026
- 387
- 330
- Operating Profit
- —
- OPM %
- —
- Other Income
- 5
- Interest
- 28
- Depreciation
- 26
- 10
- Tax %
- 0.00%
- Net Profit
- 10
- 2
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 45
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Jun 2026
- 382
- 368
- Operating Profit
- —
- OPM %
- —
- Other Income
- 3
- Interest
- 22
- Depreciation
- 27
- 16
- Tax %
- 0.00%
- Net Profit
- 16
- 0
- Equity Capital
- 48
- Reserves
- 0
- Promoter Pledge %
- 0.00%
- Equity Capital
- 48
- Reserves
- 0
- Promoter Pledge %
- 0.00%
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| 521 | 1,387 | 1,322 | 1,617 | 1,268 | 1,444 | 1,289 | 1,284 | 1,431 | |
| 458 | 1,166 | 1,062 | 1,231 | 1,188 | 1,310 | 1,384 | 1,077 | 1,288 | |
| Operating Profit | 65 | 233 | 287 | 415 | 100 | 156 | -90 | 215 | — |
| OPM % | 12 | 17 | 22 | 26 | 8 | 11 | -7 | 17 | — |
| Other Income | 2 | 12 | 28 | 29 | 20 | 23 | 5 | 8 | 8 |
| Interest | 25 | 82 | 78 | 84 | 75 | 90 | 105 | 115 | 92 |
| Depreciation | 34 | 83 | 94 | 109 | 112 | 111 | 103 | 99 | 103 |
| 6 | 68 | 115 | 222 | -91 | -45 | -488 | 1 | -2 | |
| Tax % | -2 | 1 | 0 | 0 | 36 | 50 | -16 | 0 | 0 |
| Net Profit | 6 | 67 | 115 | 221 | -58 | -22 | -567 | 1 | -2 |
| EPS | 0 | 22 | 43 | 65 | -16 | -6 | -158 | 0 | — |
| Dividend Payout % | 0 | 22 | 5 | 11 | 0 | 0 | 0 | 0 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 0 | 21 | 39 | 57 | -15 | -6 | -145 | 0 | — |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 |
| Share of Associates | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Adjusted EPS | 0 | 21 | 39 | 57 | -15 | -6 | -145 | 0 | — |
Mar 2018
- 521
- 458
- Operating Profit
- 65
- OPM %
- 12
- Other Income
- 2
- Interest
- 25
- Depreciation
- 34
- 6
- Tax %
- -2
- Net Profit
- 6
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
Mar 2019
- 1,387
- 1,166
- Operating Profit
- 233
- OPM %
- 17
- Other Income
- 12
- Interest
- 82
- Depreciation
- 83
- 68
- Tax %
- 1
- Net Profit
- 67
- EPS
- 22
- Dividend Payout %
- 22
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 21
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 21
Mar 2020
- 1,322
- 1,062
- Operating Profit
- 287
- OPM %
- 22
- Other Income
- 28
- Interest
- 78
- Depreciation
- 94
- 115
- Tax %
- 0
- Net Profit
- 115
- EPS
- 43
- Dividend Payout %
- 5
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 39
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 39
Mar 2021
- 1,617
- 1,231
- Operating Profit
- 415
- OPM %
- 26
- Other Income
- 29
- Interest
- 84
- Depreciation
- 109
- 222
- Tax %
- 0
- Net Profit
- 221
- EPS
- 65
- Dividend Payout %
- 11
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 57
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 57
Mar 2022
- 1,268
- 1,188
- Operating Profit
- 100
- OPM %
- 8
- Other Income
- 20
- Interest
- 75
- Depreciation
- 112
- -91
- Tax %
- 36
- Net Profit
- -58
- EPS
- -16
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -15
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -15
Mar 2023
- 1,444
- 1,310
- Operating Profit
- 156
- OPM %
- 11
- Other Income
- 23
- Interest
- 90
- Depreciation
- 111
- -45
- Tax %
- 50
- Net Profit
- -22
- EPS
- -6
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -6
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- -6
Mar 2024
- 1,289
- 1,384
- Operating Profit
- -90
- OPM %
- -7
- Other Income
- 5
- Interest
- 105
- Depreciation
- 103
- -488
- Tax %
- -16
- Net Profit
- -567
- EPS
- -158
- Dividend Payout %
- 0
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- -145
- Minority Interest
- -0
- Share of Associates
- 0
- Adjusted EPS
- -145
Mar 2025
- 1,284
- 1,077
- Operating Profit
- 215
- OPM %
- 17
- Other Income
- 8
- Interest
- 115
- Depreciation
- 99
- 1
- Tax %
- 0
- Net Profit
- 1
- EPS
- 0
- Dividend Payout %
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- 0
TTM
- 1,431
- 1,288
- Operating Profit
- —
- OPM %
- —
- Other Income
- 8
- Interest
- 92
- Depreciation
- 103
- -2
- Tax %
- 0
- Net Profit
- -2
- EPS
- —
- Dividend Payout %
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
- Minority Interest
- 0
- Share of Associates
- 0
- Adjusted EPS
- —
COMPOUNDED SALES GROWTH
- 10 Years:
- —
- 5 Years:
- -1%
- 3 Years:
- 0%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- -66%
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- -18%
- 3 Years:
- 18%
- 1 Year:
- -15%
RETURN ON EQUITY
- 10 Years:
- —
- 5 Years:
- -7%
- 3 Years:
- -16%
- Last Year:
- 0%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| LIABILITIES | - | - | - | - | - | - | - | - |
| Equity Capital | 25 | 26 | 27 | 36 | 36 | 36 | 36 | 40 |
| 739 | 824 | 958 | 1,549 | 1,488 | 1,463 | 896 | 1,051 | |
| 390 | 313 | 474 | 452 | 742 | 766 | 760 | 573 | |
| Trade Payables | 313 | 244 | 216 | 309 | 276 | 306 | 313 | 249 |
| 355 | 553 | 478 | 242 | 348 | 250 | 345 | 319 | |
| Total Liabilities | 1,821 | 1,960 | 2,153 | 2,588 | 2,890 | 2,821 | 2,351 | 2,232 |
| ASSETS | - | - | - | - | - | - | - | - |
| 1,063 | 1,189 | 1,368 | 1,356 | 1,332 | 1,340 | 1,266 | 1,191 | |
| Capital Work in Progress | 71 | 40 | 40 | 88 | 239 | 238 | 256 | 280 |
| 1 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | |
| 188 | 214 | 280 | 295 | 576 | 558 | 360 | 318 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 349 | 327 | |
| Cash & Bank | 47 | 76 | 57 | 199 | 47 | 9 | 9 | 4 |
| 451 | 440 | 408 | 650 | 696 | 674 | 111 | 110 | |
| Total Assets | 1,821 | 1,960 | 2,153 | 2,588 | 2,890 | 2,821 | 2,351 | 2,232 |
| Total Debt | 633 | 538 | 707 | 607 | 1,025 | 1,001 | 999 | 776 |
| Net Working Capital | -130 | -7 | -58 | 269 | 176 | 86 | -455 | -215 |
| Contingent Liabilities | 8 | 6 | 5 | 6 | 3 | 4 | 60 | 60 |
| Book Value per Share | 309.63 | 329.64 | 366.93 | 441.06 | 423.30 | 416.43 | 258.96 | 271.04 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Total Debt | 633 | 538 | 707 | 607 | 1,025 | 1,001 | 999 | 776 |
| Net Working Capital | -130 | -7 | -58 | 269 | 176 | 86 | -455 | -215 |
| Contingent Liabilities | 8 | 6 | 5 | 6 | 3 | 4 | 60 | 60 |
| Book Value per Share | 309.63 | 329.64 | 366.93 | 441.06 | 423.30 | 416.43 | 258.96 | 271.04 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Mar 2018
- Equity Capital
- 25
- 739
- 390
- Trade Payables
- 313
- 355
- Total Liabilities
- 1,821
- 1,063
- Capital Work in Progress
- 71
- 1
- 188
- 0
- Cash & Bank
- 47
- 451
- Total Assets
- 1,821
- Total Debt
- 633
- Net Working Capital
- -130
- Contingent Liabilities
- 8
- Book Value per Share
- 309.63
- Face Value
- 10.00
- Total Debt
- 633
- Net Working Capital
- -130
- Contingent Liabilities
- 8
- Book Value per Share
- 309.63
- Face Value
- 10.00
Mar 2019
- Equity Capital
- 26
- 824
- 313
- Trade Payables
- 244
- 553
- Total Liabilities
- 1,960
- 1,189
- Capital Work in Progress
- 40
- 0
- 214
- 0
- Cash & Bank
- 76
- 440
- Total Assets
- 1,960
- Total Debt
- 538
- Net Working Capital
- -7
- Contingent Liabilities
- 6
- Book Value per Share
- 329.64
- Face Value
- 10.00
- Total Debt
- 538
- Net Working Capital
- -7
- Contingent Liabilities
- 6
- Book Value per Share
- 329.64
- Face Value
- 10.00
Mar 2020
- Equity Capital
- 27
- 958
- 474
- Trade Payables
- 216
- 478
- Total Liabilities
- 2,153
- 1,368
- Capital Work in Progress
- 40
- 0
- 280
- 0
- Cash & Bank
- 57
- 408
- Total Assets
- 2,153
- Total Debt
- 707
- Net Working Capital
- -58
- Contingent Liabilities
- 5
- Book Value per Share
- 366.93
- Face Value
- 10.00
- Total Debt
- 707
- Net Working Capital
- -58
- Contingent Liabilities
- 5
- Book Value per Share
- 366.93
- Face Value
- 10.00
Mar 2021
- Equity Capital
- 36
- 1,549
- 452
- Trade Payables
- 309
- 242
- Total Liabilities
- 2,588
- 1,356
- Capital Work in Progress
- 88
- 0
- 295
- 0
- Cash & Bank
- 199
- 650
- Total Assets
- 2,588
- Total Debt
- 607
- Net Working Capital
- 269
- Contingent Liabilities
- 6
- Book Value per Share
- 441.06
- Face Value
- 10.00
- Total Debt
- 607
- Net Working Capital
- 269
- Contingent Liabilities
- 6
- Book Value per Share
- 441.06
- Face Value
- 10.00
Mar 2022
- Equity Capital
- 36
- 1,488
- 742
- Trade Payables
- 276
- 348
- Total Liabilities
- 2,890
- 1,332
- Capital Work in Progress
- 239
- 0
- 576
- 0
- Cash & Bank
- 47
- 696
- Total Assets
- 2,890
- Total Debt
- 1,025
- Net Working Capital
- 176
- Contingent Liabilities
- 3
- Book Value per Share
- 423.30
- Face Value
- 10.00
- Total Debt
- 1,025
- Net Working Capital
- 176
- Contingent Liabilities
- 3
- Book Value per Share
- 423.30
- Face Value
- 10.00
Mar 2023
- Equity Capital
- 36
- 1,463
- 766
- Trade Payables
- 306
- 250
- Total Liabilities
- 2,821
- 1,340
- Capital Work in Progress
- 238
- 2
- 558
- 0
- Cash & Bank
- 9
- 674
- Total Assets
- 2,821
- Total Debt
- 1,001
- Net Working Capital
- 86
- Contingent Liabilities
- 4
- Book Value per Share
- 416.43
- Face Value
- 10.00
- Total Debt
- 1,001
- Net Working Capital
- 86
- Contingent Liabilities
- 4
- Book Value per Share
- 416.43
- Face Value
- 10.00
Mar 2024
- Equity Capital
- 36
- 896
- 760
- Trade Payables
- 313
- 345
- Total Liabilities
- 2,351
- 1,266
- Capital Work in Progress
- 256
- 2
- 360
- 349
- Cash & Bank
- 9
- 111
- Total Assets
- 2,351
- Total Debt
- 999
- Net Working Capital
- -455
- Contingent Liabilities
- 60
- Book Value per Share
- 258.96
- Face Value
- 10.00
- Total Debt
- 999
- Net Working Capital
- -455
- Contingent Liabilities
- 60
- Book Value per Share
- 258.96
- Face Value
- 10.00
Mar 2025
- Equity Capital
- 40
- 1,051
- 573
- Trade Payables
- 249
- 319
- Total Liabilities
- 2,232
- 1,191
- Capital Work in Progress
- 280
- 2
- 318
- 327
- Cash & Bank
- 4
- 110
- Total Assets
- 2,232
- Total Debt
- 776
- Net Working Capital
- -215
- Contingent Liabilities
- 60
- Book Value per Share
- 271.04
- Face Value
- 10.00
- Total Debt
- 776
- Net Working Capital
- -215
- Contingent Liabilities
- 60
- Book Value per Share
- 271.04
- Face Value
- 10.00
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| 49 | 166 | 242 | 155 | -242 | 156 | 109 | 213 | |
| Cash from Investing | -85 | -116 | -359 | -106 | -243 | -81 | -4 | -37 |
| Cash from Financing | 68 | -23 | 97 | 92 | 334 | -113 | -106 | -180 |
| 31 | 27 | -20 | 142 | -151 | -38 | -0 | -4 | |
| Free Cash Flow | 49 | -12 | -30 | 14 | -478 | 49 | 82 | 169 |
| OCF / Net Profit | 8.25 | 2.48 | 2.11 | 0.70 | 4.15 | -7.02 | -0.19 | 394.11 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | -457 | -362 | -163 |
| OCF / Net Profit | 8.25 | 2.48 | 2.11 | 0.70 | 4.15 | -7.02 | -0.19 | 394.11 |
| Cumulative 5-Year FCF | 0 | 0 | 0 | 0 | 0 | -457 | -362 | -163 |
Mar 2018
- 49
- Cash from Investing
- -85
- Cash from Financing
- 68
- 31
- Free Cash Flow
- 49
- OCF / Net Profit
- 8.25
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 8.25
- Cumulative 5-Year FCF
- 0
Mar 2019
- 166
- Cash from Investing
- -116
- Cash from Financing
- -23
- 27
- Free Cash Flow
- -12
- OCF / Net Profit
- 2.48
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.48
- Cumulative 5-Year FCF
- 0
Mar 2020
- 242
- Cash from Investing
- -359
- Cash from Financing
- 97
- -20
- Free Cash Flow
- -30
- OCF / Net Profit
- 2.11
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 2.11
- Cumulative 5-Year FCF
- 0
Mar 2021
- 155
- Cash from Investing
- -106
- Cash from Financing
- 92
- 142
- Free Cash Flow
- 14
- OCF / Net Profit
- 0.70
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 0.70
- Cumulative 5-Year FCF
- 0
Mar 2022
- -242
- Cash from Investing
- -243
- Cash from Financing
- 334
- -151
- Free Cash Flow
- -478
- OCF / Net Profit
- 4.15
- Cumulative 5-Year FCF
- 0
- OCF / Net Profit
- 4.15
- Cumulative 5-Year FCF
- 0
Mar 2023
- 156
- Cash from Investing
- -81
- Cash from Financing
- -113
- -38
- Free Cash Flow
- 49
- OCF / Net Profit
- -7.02
- Cumulative 5-Year FCF
- -457
- OCF / Net Profit
- -7.02
- Cumulative 5-Year FCF
- -457
Mar 2024
- 109
- Cash from Investing
- -4
- Cash from Financing
- -106
- -0
- Free Cash Flow
- 82
- OCF / Net Profit
- -0.19
- Cumulative 5-Year FCF
- -362
- OCF / Net Profit
- -0.19
- Cumulative 5-Year FCF
- -362
Mar 2025
- 213
- Cash from Investing
- -37
- Cash from Financing
- -180
- -4
- Free Cash Flow
- 169
- OCF / Net Profit
- 394.11
- Cumulative 5-Year FCF
- -163
- OCF / Net Profit
- 394.11
- Cumulative 5-Year FCF
- -163
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| PER SHARE | - | - | - | - | - | - | - | - |
| EPS (₹) | 0.15 | 23.09 | 42.69 | 61.62 | -16.15 | -6.16 | -157.61 | 0.13 |
| Book Value (₹) | 309.63 | 329.64 | 366.93 | 441.06 | 423.30 | 416.43 | 258.96 | 271.04 |
| Dividend per Share (₹) | 0.00 | 5.00 | 2.00 | 7.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 14.92 | 53.71 | 71.63 | 84.65 | 13.83 | 22.77 | -118.69 | 24.79 |
| PROFITABILITY | - | - | - | - | - | - | - | - |
| Operating Margin % | 12.47% | 15.92% | 21.71% | 25.64% | 7.88% | 10.83% | -7.38% | 16.07% |
| Net Margin % | 1.15% | 4.84% | 8.66% | 13.69% | -4.60% | -1.54% | -43.99% | 0.04% |
| ROE % | 0.78% | 8.32% | 12.48% | 17.23% | -3.75% | -1.47% | -46.64% | 0.05% |
| ROCE % | 2.22% | 10.38% | 11.73% | 15.34% | -0.67% | 1.79% | -17.29% | 6.07% |
| 0.33% | 3.55% | 5.57% | 9.34% | -2.13% | -0.78% | -21.93% | 0.02% | |
| EFFICIENCY | - | - | - | - | - | - | - | - |
| Debtor Days | 184 | 73 | 71 | 80 | 140 | 130 | 125 | 96 |
| Inventory Days | 131 | 53 | 68 | 65 | 125 | 143 | 130 | 96 |
| Payable Days | 420 | 144 | 140 | 132 | 163 | 135 | 140 | 164 |
| -105 | -19 | -1 | 13 | 102 | 138 | 115 | 29 | |
| FINANCIAL HEALTH | - | - | - | - | - | - | - | - |
| Debt to Equity (x) | 0.83x | 0.63x | 0.72x | 0.38x | 0.67x | 0.67x | 1.07x | 0.71x |
| Interest Coverage (x) | 1.23x | 1.82x | 2.48x | 3.62x | -0.21x | 0.50x | -3.65x | 1.00x |
| 0.82x | 0.99x | 0.92x | 1.34x | 1.17x | 1.08x | 0.63x | 0.77x | |
| GROWTH | - | - | - | - | - | - | - | - |
| Revenue Growth % | 0.00% | 166.17% | -4.68% | 22.33% | -21.56% | 13.83% | -10.73% | -0.40% |
| Operating Profit Growth % | 0.00% | 259.05% | 23.06% | 44.49% | -75.89% | 56.45% | -157.41% | 338.95% |
| Net Profit Growth % | 0.00% | 1024.35% | 70.70% | 93.29% | -126.33% | 61.83% | -2448.13% | 100.10% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -2458.12% | 100.09% | |
| VALUATION | - | - | - | - | - | - | - | - |
| P/E (x) | 0.00x | 18.15x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 3820.42x |
| P/B (x) | 0.00x | 1.27x | 0.00x | 0.00x | 0.00x | 0.00x | 1.44x | 1.89x |
| Dividend Yield % | 0.00% | 1.19% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 6.61x | 0.00x | 0.00x | 0.00x | 0.00x | -25.96x | 13.21x |
Mar 2018
- EPS (₹)
- 0.15
- Book Value (₹)
- 309.63
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 14.92
- Operating Margin %
- 12.47%
- Net Margin %
- 1.15%
- ROE %
- 0.78%
- ROCE %
- 2.22%
- 0.33%
- Debtor Days
- 184
- Inventory Days
- 131
- Payable Days
- 420
- -105
- Debt to Equity (x)
- 0.83x
- Interest Coverage (x)
- 1.23x
- 0.82x
- Revenue Growth %
- 0.00%
- Operating Profit Growth %
- 0.00%
- Net Profit Growth %
- 0.00%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2019
- EPS (₹)
- 23.09
- Book Value (₹)
- 329.64
- Dividend per Share (₹)
- 5.00
- Cash EPS (₹)
- 53.71
- Operating Margin %
- 15.92%
- Net Margin %
- 4.84%
- ROE %
- 8.32%
- ROCE %
- 10.38%
- 3.55%
- Debtor Days
- 73
- Inventory Days
- 53
- Payable Days
- 144
- -19
- Debt to Equity (x)
- 0.63x
- Interest Coverage (x)
- 1.82x
- 0.99x
- Revenue Growth %
- 166.17%
- Operating Profit Growth %
- 259.05%
- Net Profit Growth %
- 1024.35%
- 0.00%
- P/E (x)
- 18.15x
- P/B (x)
- 1.27x
- Dividend Yield %
- 1.19%
- 6.61x
Mar 2020
- EPS (₹)
- 42.69
- Book Value (₹)
- 366.93
- Dividend per Share (₹)
- 2.00
- Cash EPS (₹)
- 71.63
- Operating Margin %
- 21.71%
- Net Margin %
- 8.66%
- ROE %
- 12.48%
- ROCE %
- 11.73%
- 5.57%
- Debtor Days
- 71
- Inventory Days
- 68
- Payable Days
- 140
- -1
- Debt to Equity (x)
- 0.72x
- Interest Coverage (x)
- 2.48x
- 0.92x
- Revenue Growth %
- -4.68%
- Operating Profit Growth %
- 23.06%
- Net Profit Growth %
- 70.70%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2021
- EPS (₹)
- 61.62
- Book Value (₹)
- 441.06
- Dividend per Share (₹)
- 7.00
- Cash EPS (₹)
- 84.65
- Operating Margin %
- 25.64%
- Net Margin %
- 13.69%
- ROE %
- 17.23%
- ROCE %
- 15.34%
- 9.34%
- Debtor Days
- 80
- Inventory Days
- 65
- Payable Days
- 132
- 13
- Debt to Equity (x)
- 0.38x
- Interest Coverage (x)
- 3.62x
- 1.34x
- Revenue Growth %
- 22.33%
- Operating Profit Growth %
- 44.49%
- Net Profit Growth %
- 93.29%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2022
- EPS (₹)
- -16.15
- Book Value (₹)
- 423.30
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 13.83
- Operating Margin %
- 7.88%
- Net Margin %
- -4.60%
- ROE %
- -3.75%
- ROCE %
- -0.67%
- -2.13%
- Debtor Days
- 140
- Inventory Days
- 125
- Payable Days
- 163
- 102
- Debt to Equity (x)
- 0.67x
- Interest Coverage (x)
- -0.21x
- 1.17x
- Revenue Growth %
- -21.56%
- Operating Profit Growth %
- -75.89%
- Net Profit Growth %
- -126.33%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2023
- EPS (₹)
- -6.16
- Book Value (₹)
- 416.43
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 22.77
- Operating Margin %
- 10.83%
- Net Margin %
- -1.54%
- ROE %
- -1.47%
- ROCE %
- 1.79%
- -0.78%
- Debtor Days
- 130
- Inventory Days
- 143
- Payable Days
- 135
- 138
- Debt to Equity (x)
- 0.67x
- Interest Coverage (x)
- 0.50x
- 1.08x
- Revenue Growth %
- 13.83%
- Operating Profit Growth %
- 56.45%
- Net Profit Growth %
- 61.83%
- 0.00%
- P/E (x)
- 0.00x
- P/B (x)
- 0.00x
- Dividend Yield %
- 0.00%
- 0.00x
Mar 2024
- EPS (₹)
- -157.61
- Book Value (₹)
- 258.96
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- -118.69
- Operating Margin %
- -7.38%
- Net Margin %
- -43.99%
- ROE %
- -46.64%
- ROCE %
- -17.29%
- -21.93%
- Debtor Days
- 125
- Inventory Days
- 130
- Payable Days
- 140
- 115
- Debt to Equity (x)
- 1.07x
- Interest Coverage (x)
- -3.65x
- 0.63x
- Revenue Growth %
- -10.73%
- Operating Profit Growth %
- -157.41%
- Net Profit Growth %
- -2448.13%
- -2458.12%
- P/E (x)
- 0.00x
- P/B (x)
- 1.44x
- Dividend Yield %
- 0.00%
- -25.96x
Mar 2025
- EPS (₹)
- 0.13
- Book Value (₹)
- 271.04
- Dividend per Share (₹)
- 0.00
- Cash EPS (₹)
- 24.79
- Operating Margin %
- 16.07%
- Net Margin %
- 0.04%
- ROE %
- 0.05%
- ROCE %
- 6.07%
- 0.02%
- Debtor Days
- 96
- Inventory Days
- 96
- Payable Days
- 164
- 29
- Debt to Equity (x)
- 0.71x
- Interest Coverage (x)
- 1.00x
- 0.77x
- Revenue Growth %
- -0.40%
- Operating Profit Growth %
- 338.95%
- Net Profit Growth %
- 100.10%
- 100.09%
- P/E (x)
- 3820.42x
- P/B (x)
- 1.89x
- Dividend Yield %
- 0.00%
- 13.21x
Documents
Announcements
- Updates
2026-08-19 - Solara Active Pharma Sciences Limited has informed the Exchange regarding Conversion of partly paid-up Rights Equity Shares into fully paid-up equity shares in Conversion of partly paid-up Rights Equity Shares into fully paid-up equity shares in relation to the rights issue by the Company, upon receipt of the Call Monies, as applicable.
- ESOP/ESOS/ESPS
2026-08-18 - Solara Active Pharma Sciences Limited has informed the Exchange regarding allotment of 2250 equity shares pursuant to exercise of ESOP options.
Annual Reports
Credit Ratings
- Credit Rating
2026-06-23 - Solara Active Pharma Sciences Limited has informed the Exchange about Credit Rating
Concalls
Jul 2026
May 2026
Feb 2026